SCHEMBL31034909

SCHEMBL31034909

CCC1(c2ncn(C(=O)N(C)C)n2)Cc2ccccc2C1

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 1/20 0.36
ADRA2B P18089 1/20 0.36
ADRA2C P18825 1/20 0.36
ADRA1B P35368 1/20 0.36
POLB P06746 1/20 0.36
HRH3 Q9Y5N1 1/20 0.34
ATM Q13315 1/20 0.32
DAGLA Q9Y4D2 3/20 0.32
KIF11 P52732 2/20 0.31
KCNH2 Q12809 1/20 0.31
RYR2 Q92736 1/20 0.30
TSHR P16473 1/20 0.30
MGLL Q99685 2/20 0.30
TRPV1 Q8NER1 1/20 0.30
ALDH1A1 P00352 1/20 0.30
SCN4A P35499 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31034870 0.75 FAAH (0.39) ADRA2AADRA2BADRA2CADRA1BPOLB
SCHEMBL31034919 0.72 ADRA2A (0.39) ADRA2AADRA2BADRA2CADRA1BPOLB
SCHEMBL31034900 0.69 FAAH (0.43) ADRA2AADRA2BADRA2CADRA1BPOLB
SCHEMBL31034887 0.68 POLB (0.41) ADRA2AADRA2BADRA2CADRA1BPOLB
SCHEMBL31034854 0.66 ADRA2A (0.37) ADRA2AADRA2BADRA2CADRA1B
SCHEMBL16848182 0.66 DAGLA (0.34) DAGLAMGLLTRPV1SCN4A
SCHEMBL2179538 0.65 BCHE (0.48) DAGLAMGLLTRPV1ALDH1A1
SCHEMBL18179632 0.63 ALDH1A1 (0.34) DAGLATSHRMGLLTRPV1ALDH1A1
SCHEMBL31034829 0.62 ADRA2A (0.51) ADRA2AADRA2BADRA2CADRA1BTSHR
SCHEMBL5376216 0.62 NPC1 (0.52) DAGLATSHRMGLLTRPV1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4658639-A1 N,N-DIALKYL-4-(2-ETHYLINDAN-2-YL)-1H-IMIDAZOLE-1-CARBOXAMIDES AND RELATED COMPOUNDS FOR TREATMENT OF NEURODEGENERATIVE DISEASES Univerza V Ljubljani (SI) 2025-12-10 EP claimed
WO-2024160908-A1 N,N-DIALKYL-4-(2-ETHYLINDAN-2-YL)-1H-IMIDAZOLE-1-CARBOXAMIDES AND RELATED COMPOUNDS FOR TREATMENT OF NEURODEGENERATIVE DISEASES UNIVERZA V LJUBLJANI (SI) 2024-08-08 WO claimed
EP-4658639-A1 N,N-DIALKYL-4-(2-ETHYLINDAN-2-YL)-1H-IMIDAZOLE-1-CARBOXAMIDES AND RELATED COMPOUNDS FOR TREATMENT OF NEURODEGENERATIVE DISEASES Univerza V Ljubljani (SI) 2025-12-10 EP disclosed
WO-2024160908-A1 N,N-DIALKYL-4-(2-ETHYLINDAN-2-YL)-1H-IMIDAZOLE-1-CARBOXAMIDES AND RELATED COMPOUNDS FOR TREATMENT OF NEURODEGENERATIVE DISEASES UNIVERZA V LJUBLJANI (SI) 2024-08-08 WO disclosed